1,997
Views
14
CrossRef citations to date
0
Altmetric
Hemoglobinopathy

rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients

, , , , , , , & show all

References

  • Rucknagel D, Ferrucci S, Whitten CF, Sarniak I, Odenheimer D, Sing C, et al. alpha-Thalassemia and HbF concentration in sickle cell anemia. Prog Clin Biol Res. 1984;165:103–20.
  • Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008;322(5909):1839–42. doi: 10.1126/science.1165409
  • Eridani S, Avemaria F, Mosca A. Reactivation of fetal hemoglobin in thalassemia and sickle cell disease. Thalassemia Reports 2014;4:2196. doi: 10.4081/thal.2014.2196
  • Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(20):1317–22. doi: 10.1056/NEJM199505183322001
  • McGann PT, Ware RE. Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?. Curr Opin Hematol. 2011;18(3):158–65. doi: 10.1097/MOH.0b013e32834521dd
  • Brandow AM, Jirovec DL, Panepinto JA. Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. Am J Hematol. 2010;85(8):611–3. doi: 10.1002/ajh.21749
  • Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature 2009;460(7259):1093–7. doi: 10.1038/nature08243
  • Xu J, Sankaran VG, Ni M, Menne TF, Puran RV, Kim N, et al. Transcriptional silencing of gamma-globin by BCL11A involves long range interactions and cooperation with SOX6. Genes Dev. 2010;24(8):783–98. doi: 10.1101/gad.1897310
  • Jawaid K, Wahlberg K, Thein SL, Best S. Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus. Blood Cells Mol Dis. 2010;45:140–6. doi: 10.1016/j.bcmd.2010.05.006
  • Menzel S, Garner C, Gut I, Matsuda F, Yamaguchi M, Heath S, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet. 2007;39:1197–9. doi: 10.1038/ng2108
  • Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA 2008;105:1620–5. doi: 10.1073/pnas.0711566105
  • Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Letter G. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010;42:1049–51. doi: 10.1038/ng.707
  • Bradner JE, Maka R, Tanguturia SK, Mazitscheka R, Haggartya SJ, Rossa K, et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci USA 2010;107:12617–22. doi: 10.1073/pnas.1006774107
  • Xu JD, Bauer DE, Kerenyi MA, Voa TD, Hou S, Hsu YJ, et al. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proc Natl Acad Sci USA 2013;110(16):6518–23. doi: 10.1073/pnas.1303976110
  • Bendaoud B, Hosni I, Mosbahi I, Hafsia R, Prehu C, Abbes S. Three new mutations account for the prevalence of glucose 6 phosphate deshydrogenase (G6PD) deficiency in Tunisia. Pathol Biol (Paris) 2013;61:64–9. doi: 10.1016/j.patbio.2012.03.005
  • Lettre G, Sanaran VG, Bezerra MAC, Araujo AS, Uda M, Sanna S, et al. DNA polymorphisms at the BCL11A; HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008;105:11869–74. doi: 10.1073/pnas.0804799105
  • Sheehan VA, Luo Z, Flanagan JM, Howard TA, Thompson BW, Wang WC, et al. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am J Hematol. 2013;88:571–6. doi: 10.1002/ajh.23457
  • Moumni I, Ben Mustapha M, Ben Mansour I, Zoraı A, Douzi K, Sassi S, et al. Fetal hemoglobin in Tunisian sickle cell disease patient: relationship with polymorphic sequences cis to the β-globin gene. Indian J Hematol Blood Transfus. 2015; doi:10.1007/s12288-015-0504-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.